tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TRML Stock Latest News

Tourmaline Bio’s Promising Drug Developments and Strategic Positioning Make It a Top Pick for 2024
RatingsTourmaline Bio’s Promising Drug Developments and Strategic Positioning Make It a Top Pick for 2024
3d ago
TRML
Tourmaline Bio’s Pacibekitug: A Promising Contender in ASCVD Treatment with Undervalued Potential
PremiumRatings
Tourmaline Bio’s Pacibekitug: A Promising Contender in ASCVD Treatment with Undervalued Potential
3d ago
TRML
Tourmaline Bio presents data from ongoing Phase 2 TRANQUILITY trial
PremiumThe Fly
Tourmaline Bio presents data from ongoing Phase 2 TRANQUILITY trial
5d ago
TRML
Tourmaline Bio’s Strategic Advancements and Promising Clinical Trial Results Reinforce Buy Rating
PremiumRatings
Tourmaline Bio’s Strategic Advancements and Promising Clinical Trial Results Reinforce Buy Rating
22d ago
TRML
Tourmaline Bio’s Promising Developments and Strategic Potential: Analyst Recommends ‘Buy’ Rating
PremiumRatings
Tourmaline Bio’s Promising Developments and Strategic Potential: Analyst Recommends ‘Buy’ Rating
22d ago
TRML
Tourmaline Bio Reports Positive Trial Results and Strong Cash Position
PremiumCompany AnnouncementsTourmaline Bio Reports Positive Trial Results and Strong Cash Position
24d ago
TRML
Tourmaline Bio: Strong Financial Position and Promising Cardiovascular Treatment Pipeline Justify Buy Rating
Premium
Ratings
Tourmaline Bio: Strong Financial Position and Promising Cardiovascular Treatment Pipeline Justify Buy Rating
24d ago
TRML
Tourmaline Bio reports Q2 EPS (90c), consensus (93c)
Premium
The Fly
Tourmaline Bio reports Q2 EPS (90c), consensus (93c)
24d ago
TRML
3 Best Stocks to Buy Now, 7/24/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/24/2025, According to Top Analysts
1M ago
PR
APP
Tourmaline Bio management to meet with Piper Sandler
PremiumThe Fly
Tourmaline Bio management to meet with Piper Sandler
2M ago
TRML
Tourmaline Bio Releases Updated Corporate Presentation
PremiumCompany Announcements
Tourmaline Bio Releases Updated Corporate Presentation
3M ago
8K
TRML
Tourmaline Bio Elects Directors and Ratifies Auditor
PremiumCompany Announcements
Tourmaline Bio Elects Directors and Ratifies Auditor
3M ago
8K
TRML
Promising Phase 2 Trial Results and Strategic Advantages Justify Buy Rating for Tourmaline Bio
PremiumRatingsPromising Phase 2 Trial Results and Strategic Advantages Justify Buy Rating for Tourmaline Bio
3M ago
TRML
Promising Potential of Tourmaline Bio’s TOUR006: A Strong Buy Recommendation
Premium
Ratings
Promising Potential of Tourmaline Bio’s TOUR006: A Strong Buy Recommendation
4M ago
TRML
Buy Rating for Tourmaline Bio Driven by Promising Clinical Results and Market Potential
Premium
Ratings
Buy Rating for Tourmaline Bio Driven by Promising Clinical Results and Market Potential
4M ago
TRML
Tourmaline Bio Announces Positive Phase 2 Trial Results
PremiumCompany Announcements
Tourmaline Bio Announces Positive Phase 2 Trial Results
4M ago
8K
TRML
Tourmaline Bio announces results from ongoing Phase 2 TRANQUILITY trial
PremiumThe Fly
Tourmaline Bio announces results from ongoing Phase 2 TRANQUILITY trial
4M ago
TRML
Buy Rating for Tourmaline Bio: Anticipated Catalyst from Phase 2 TRANQUILITY Study on Pacibekitug
PremiumRatings
Buy Rating for Tourmaline Bio: Anticipated Catalyst from Phase 2 TRANQUILITY Study on Pacibekitug
4M ago
TRML
Tourmaline Bio’s Pacibekitug: A Promising IL-6 Inhibitor for ASCVD with Strong Buy Rating
PremiumRatings
Tourmaline Bio’s Pacibekitug: A Promising IL-6 Inhibitor for ASCVD with Strong Buy Rating
4M ago
TRML
Tourmaline Bio’s Promising Clinical Developments and Strategic Expansion Drive Buy Rating
PremiumRatingsTourmaline Bio’s Promising Clinical Developments and Strategic Expansion Drive Buy Rating
4M ago
TRML
Tourmaline Bio Reports Q1 2025 Financial Results
Premium
Company Announcements
Tourmaline Bio Reports Q1 2025 Financial Results
4M ago
TRML
Tourmaline Bio’s Promising Clinical Trials and Strong Financial Position Justify Buy Rating
Premium
Ratings
Tourmaline Bio’s Promising Clinical Trials and Strong Financial Position Justify Buy Rating
4M ago
TRML

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >